DePuy ASR Hip Replacement Recall By The FDA - d'Oliveira & Associates

The DePuy ASR hip replacement system has been identified as posing serious risks to implant recipients, including hip failure and dispersal of metallic debris in patients’ bodies. If you or a loved one has been harmed due to DePuy ASR hip implants, the personal injury attorneys at the Law Offices of d’Oliveira & Associates can help. You may want to speak to an injury lawyer who can assist you with making important personal and legal decisions. If needed, an injury attorney can help you get the compensation you deserve by filing a lawsuit on your behalf.
For information on the DePuy Pinnacle hip replacement, which may also be defective, please click here

Following an earlier warning to physicians about the high failure rate associated with the DePuy ASR hip replacement system, the FDA has instituted a DePuy ASR recall. On July 17, 2010 the FDA indicated that the subsidiary of Johnson and Johnson, DePuy Orthopaedics, notified clinicians of new failure rate information obtained after revision, concerning the DePuy ASR hip replacement system. This physician notification, along with the market withdrawal of DePuy ASR, prompted the FDA to designate DePuy Orthopaedics’ actions as a Class 2 medical implant recall.

Initially DePuy, the company that manufactures the hip replacement system, indicated that the device’s market withdrawal was due to slow sales, rather than due to any safety problems. However, DePuy notified clinicians, on March 6, that the ASR hip implant had been linked to a high failure rate. DePuy identified several patients who received ASR hip replacements and had suffered hip failures soon after. As a result, many patients who experienced hip failures after receiving ASR hip replacements have been required to undergo several additional hip surgeries. Such surgeries may entail, among other things, removal or correction of the implants which have proven defective

The DePuy ASR Hip Replacement Recall Includes:

• 300 Acetabular Implants in cup sizes running from 44 millimeters to 70 millimeters
• 29 models of the ASR 100.

The risk of experiencing problems associated with the device has been identified as the highest in women using devices below 50 millimeters in diameter.

The DePuy ASR emerged in 2005 and is a metal-on-metal hip replacement system. Metal-on-metal hip implants increasingly have been identified as posing various health risks, in that they may disperse metal particles into the body.
Such a shedding of particles can cause tissue damage and deterioration, inflammatory reactions, and can lead to bone loss.

Adverse reports concerning DePuy ASR hip implants began to arise in 2007 with approximately 100 patients coming forward to identify problems with the hip replacement system. In 2008, the number of patients reporting adverse events associated with DePuy ASR hip implants rose to over 200 individuals. In 2009, reports of DePuy ASR hip implant problems reached a high of 300.

Studies have shown that approximately 12 to 13 percent of patients that have undergone hip replacement surgery with DePuy ASR devices will need corrective surgery within five years. These individuals who have received metal-on-metal hip implants will have to have this corrective surgery and/or have the defective hip implants replaced because of the dangerous nature of the metal debris. Patients have been advised that they should see their implant surgeons immediately for an evaluation of the DePuy ASR hip replacement system’s performance.

Contact the Law Offices of d'Oliveira & Associates

If you believe that you or a loved one has suffered as a result of a DePuy ASR hip replacement system, you may want to speak with a personal injury attorney regarding a potential lawsuit. An injury lawyer familiar with new developments in the investigation of DePuy hip implants may be able to help you make important personal and legal decisions.

Please contact the law offices of d'Oliveira & Associates at 1-800-992-6878 or fill out a contact form for a free legal consultation#.